Lundbeck is a global pharmaceutical company that has been at the forefront of brain science for over 70 years. With a deep commitment to restoring brain health, Lundbeck focuses on developing transformative therapies for a wide range of brain diseases, including Alzheimer's disease, Parkinson's disease, schizophrenia, and depression. With a strong emphasis on research and partnerships, Lundbeck's dedicated team of nearly 1,000 employees in the United States works tirelessly to address the unmet medical needs of patients and their communities.
As the largest affiliate of H. Lundbeck A/S, Lundbeck US operates from its headquarters in Deerfield, Illinois, and scientific operations in California and Washington. With a deep pipeline of targeted treatments for brain diseases and a passion for patients, Lundbeck stands apart in its commitment to uncovering the underlying biology of challenging disorders and addressing unmet medical needs with urgency and compassion.
Generated from the website